Mathematical modeling of cancer immunotherapy for personalized clinical translation

被引:0
|
作者
Joseph D. Butner
Prashant Dogra
Caroline Chung
Renata Pasqualini
Wadih Arap
John Lowengrub
Vittorio Cristini
Zhihui Wang
机构
[1] Houston Methodist Research Institute,Mathematics in Medicine Program
[2] The University of Texas MD Anderson Cancer Center,Department of Radiation Oncology
[3] Rutgers Cancer Institute of New Jersey,Department of Radiation Oncology
[4] Division of Cancer Biology,Department of Medicine
[5] Rutgers New Jersey Medical School,Department of Mathematics
[6] Division of Hematology/Oncology,Neal Cancer Center
[7] Rutgers New Jersey Medical School,Department of Imaging Physics
[8] University of California at Irvine,Physiology, Biophysics, and Systems Biology Program
[9] Houston Methodist Research Institute,Department of Physiology and Biophysics
[10] University of Texas MD Anderson Cancer Center,undefined
[11] Graduate School of Medical Sciences,undefined
[12] Weill Cornell Medicine,undefined
[13] Weill Cornell Medicine,undefined
来源
Nature Computational Science | 2022年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Encouraging advances are being made in cancer immunotherapy modeling, especially in the key areas of developing personalized treatment strategies based on individual patient parameters, predicting treatment outcomes and optimizing immunotherapy synergy when used in combination with other treatment approaches. Here we present a focused review of the most recent mathematical modeling work on cancer immunotherapy with a focus on clinical translatability. It can be seen that this field is transitioning from pure basic science to applications that can make impactful differences in patients’ lives. We discuss how researchers are integrating experimental and clinical data to fully inform models so that they can be applied for clinical predictions, and present the challenges that remain to be overcome if widespread clinical adaptation is to be realized. Lastly, we discuss the most promising future applications and areas that are expected to be the focus of extensive upcoming modeling studies.
引用
收藏
页码:785 / 796
页数:11
相关论文
共 50 条
  • [1] Mathematical modeling of cancer immunotherapy for personalized clinical translation
    Butner, Joseph D.
    Dogra, Prashant
    Chung, Caroline
    Pasqualini, Renata
    Arap, Wadih
    Lowengrub, John
    Cristini, Vittorio
    Wang, Zhihui
    NATURE COMPUTATIONAL SCIENCE, 2022, 2 (12): : 785 - 796
  • [2] Mathematical Modeling in Immunotherapy of Cancer: Personalizing Clinical Trials
    Agur, Zvia
    Vuk-Pavlovic, Stanimir
    MOLECULAR THERAPY, 2012, 20 (01) : 1 - 2
  • [3] Mathematical modeling of cancer response to immunotherapy
    Ashi, H. A.
    Simbawa, Eman
    APPLIED MATHEMATICS IN SCIENCE AND ENGINEERING, 2025, 33 (01):
  • [4] Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models
    Kronik, Natalie
    Kogan, Yuri
    Elishmereni, Moran
    Halevi-Tobias, Karin
    Vuk-Pavlovic, Stanimir
    Agur, Zvia
    PLOS ONE, 2010, 5 (12):
  • [5] Cancer immunotherapy, mathematical modeling and optimal control
    Castiglione, F.
    Piccoll, B.
    JOURNAL OF THEORETICAL BIOLOGY, 2007, 247 (04) : 723 - 732
  • [6] Mathematical modeling of the synergistic combination of cancer immunotherapy and radiotherapy
    Ceberg, C.
    Ahlstedt, J.
    Nittby, H. Redebrant
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S862 - S862
  • [7] Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
    Serre, Raphael
    Benzekry, Sebastien
    Padovani, Laetitia
    Meille, Christophe
    Andre, Nicolas
    Ciccolini, Joseph
    Barlesi, Fabrice
    Muracciole, Xavier
    Barbolosi, Dominique
    CANCER RESEARCH, 2016, 76 (17) : 4931 - 4940
  • [8] Personalized immunotherapy for cancer
    Pasetto, Anna
    Lu, Yong-Chen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
    Yu, Meihua
    Yang, Wei
    Yue, Wenwen
    Chen, Yu
    ADVANCED SCIENCE, 2022, 9 (35)
  • [10] Advances in personalized cancer immunotherapy
    Kazuhiro Kakimi
    Takahiro Karasaki
    Hirokazu Matsushita
    Tomoharu Sugie
    Breast Cancer, 2017, 24 : 16 - 24